About this trial
The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The investigators aimed at developing a database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative personal and with the University hospital computer science department. The main objective is to study the predictive factors associated with the change of functional autonomy level, measured every 6 months to 12 months by phone, in a Memory Clinic. The study population would consist in about 1000 patients with ADRD. The length of follow-up of each patient will be 3 years.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who undergo a medical visit in the Memory Clinic for the 1st time
Patients living at home or in housing
Patients with memory impairment, at all stage of the disease
Disqualifiers
Patients in institution
Patients under legal protection
Patients with a hearing or visual impairment, which dot not allow to carry out the examination
Trial design
Single group
Treatments tested in this trial
The Lawton Instrumental Activities of Daily Living score (IADL), and the disability assessment of dementia score (DAD-6
Other intervention
Treatment groups
Trial outcomes
Primary outcomes
Functional autonomy level
The scores of "Lawton Instrumental Activities of Daily Living" (IADL) and of "Disability Assessment of Dementia" (DAD-6)
Secondary outcomes
Cognitive function level
Mini Mental Test examination (MMSE)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.